Skip to main content

Table 1 Clinical information of patients with hepatocellular carcinoma in three datasets

From: An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients

Characteristics TCGA (N = 319) ICGC (N = 232) GSE76427 (N = 94)
Age (years) (%)
 ≤ 60 160 (50.2) 49 (21.1) 43 (45.7)
 > 60 159 (49.8) 183 (78.9) 51 (54.3)
Gender (%)
 Female 100 (31.3) 61 (26.3) 12 (12.8)
 Male 219 (68.7) 171 (73.7) 82 (87.2)
Grade (%)
 G1 44 (13.8) NA NA
 G2 154 (48.3) NA NA
 G3 109 (34.1) NA NA
 G4 12 (3.8) NA NA
AJCC stage (%)
 Stage I 160 (50.2) 36 (15.5) 41 (43.6)
 Stage II 76 (23.8) 104 (44.8) 31 (33.0)
 Stage III 80 (25.1) 73 (31.5) 19 (20.2)
 Stage IV 3 (0.9) 19 (8.2) 3 (3.2)
Survival status (%)
 Alive 215 (67.4) 189 (81.5) 74 (78.7)
 Deceased 104 (32.6) 43 (18.5) 20 (21.3)
\